ClinicalTrials.Veeva

Menu

Clinical Value of Self-assessment Risk of Osteoporosis in Chinese

H

Hongmei Zhang

Status

Completed

Conditions

Osteoporosis

Treatments

Other: questionaire

Study type

Observational

Funder types

Other

Identifiers

NCT02594592
WuhanITCWMH

Details and patient eligibility

About

This cross-sectional study aimed to validate the effectiveness of the combined use of the Osteoporosis Self-Assessment Tool for Asians (OSTA) and the One-Minute Osteoporosis Risk Test (IOF test) in a population from Wuhan, China.

Full description

This cross-sectional study was a field investigation. A total of 400 Wuhan residents who visited the Health Examination Department at our hospital were invited to participate in this study. Potential participants were informed of the aim and procedures and were asked to sign an informed consent form before participation. Inclusion criteria were as follows: age of at least 20 years, able to read and fill out the questionnaire, and willingness to participate. Exclusion criteria were as follows: severe liver, heart, or kidney impairment, and tumor. Procedures of the study were in accordance with the Declaration of Helsinki and were approved by the local ethics committee.

The study population was divided into four groups according to age and sex: Younger Women (age ≤ 55 years), Younger Men (age ≤ 55 years), Older Women (age > 55 years), and Older Men (age > 55 years). A research assistant and a nurse distributed the Chinese version of the IOF test to participants. The Chinese version of the IOF test includes 10 questions, two of which are specific to women and one to men. The maximum number of risk factors is 8 for women and 9 for men. Individuals were regarded as susceptible to osteoporosis risk if they answered "yes" to any of the 10 questions.

To assess the grade of osteoporosis risk, the OSTA index was calculated by the equation (body weight (kg) - age (years))*0.2. An OSTA index of -1 to -4 is regarded as medium risk, greater than -1 as low risk, and less than -4 as high risk.

Enrollment

389 patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age of at least 20 years, able to read and fill out the questionnaire, and willingness to participate.

Exclusion criteria

  • severe liver, heart, or kidney impairment, and tumor. Procedures of the study were in accordance with the Declaration of Helsinki and were approved by the local ethics committee.

Trial design

389 participants in 4 patient groups

Younger Women
Description:
Younger Women (age ≤ 55 years),complete questionaire
Treatment:
Other: questionaire
Younger Men
Description:
Younger Men (age ≤ 55 years),complete questionaire
Treatment:
Other: questionaire
Older Men
Description:
Older Men (age \> 55 years). complete questionaire
Treatment:
Other: questionaire
Older Women
Description:
Older Women (age \> 55 years),complete questionaire
Treatment:
Other: questionaire

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems